반응식
[C:1]([OH:13])(=[O:12])/[CH:2]=[CH:3]/[C:4]1[CH:11]=[CH:10][C:8]([OH:9])=[C:6]([OH:7])[CH:5]=1.[CH:14]1[C:19]([CH2:20][CH2:21]O)=[CH:18][C:17]([OH:23])=[C:16]([OH:24])[CH:15]=1.C1C(CCO)=CC=C(O)C=1.OC1C=C(CCC2C(O)=C(O)C=CC=2/C=C/C([O-])=O)C=CC=1O>>[C:1]([O:13][CH2:21][CH2:20][C:19]1[CH:14]=[CH:15][C:16]([OH:24])=[C:17]([OH:23])[CH:18]=1)(=[O:12])/[CH:2]=[CH:3]/[C:4]1[CH:11]=[CH:10][C:8]([OH:9])=[C:6]([OH:7])[CH:5]=1참가 물질
5
실험 절차
The protocol derived from Example 14 above is applied with caffeic acid and 3-hydroxytyrosol instead of caffeic acid and tyrosol; the compound obtained is 2-(3,4-dihydroxyphenylethyl)trans-caffeoate (formula IVb2).
후처리
- customthe compound obtained
출처 및 근거
- ORD 기록
- ord-93712a061f204d259f75aaebaf1cb619
- 출처 데이터셋
- uspto-grants-2015_07
- 특허 번호
- US09089499B2
연결된 노트
불러오는 중…